Romulus’ Story: A Guardian Dog’s Cancer Tale
At FidoCure, we believe every dog deserves a chance to live their best life, even when faced with challenging diagnoses. The story of Romulus, a beloved Maremma guardian dog, is a testament to the power of personalized veterinary care.
When Romulus was initially diagnosed with bone cancer, his primary veterinarian, Dr. Jennifer Enger at Mid-Hudson Veterinary Practice, recommended amputation. While amputation is the most common treatment for canine bone cancer, it would have significantly impaired Romulus' quality of life, as he was a dedicated protector of his family's chicken coops. The original prognosis estimated that Romulus had just 6-9 months to live—a devastating outlook for a dog known for his big smile and friendly demeanor.
However, Romulus' family and Dr. Enger were not ready to give up on him and decided to enroll him in the FidoCure platform. Through our innovative approach, we provided an AI-driven precision medicine treatment plan that exceeded initial expectations. Instead of the anticipated 6-9 month timeline, Romulus thrived for an additional four years. These extra years allowed his family to spend more precious time with their beloved dog and enabled Romulus to continue his important work of guarding the farm and helping train the next generation of puppies.
As the O'Donohue family shared, "Without Christina Lopes and her passion to help dogs with bone cancer, Romulus' diagnosis would have been grave. Thanks to Christina and the amazing FidoCure team, Romulus lived an additional four years with targeted therapy treatment guided by FidoCure's precision medicine platform and helped train our puppies."
Romulus has since passed, but he is fondly remembered by his four-pawed friends and the humans who knew him. His story serves as a powerful reminder of the significant difference that AI-driven precision medicine can make.
To the O'Donohue family and all the pet parents who trust us with the care of their beloved pets: thank you. Your faith in our mission inspires us to continue pushing boundaries and setting new standards for veterinary oncology.